News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Bayer Corporation Gets Japan Approval for Kidney Cancer Drug
January 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, Jan 28 (Reuters) - German drug maker Bayer AG said on Monday its drug Nexavar had been approved in Japan for the treatment of advanced kidney cancer, beating rival makers of similar therapies to the market here.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Bayer
MORE ON THIS TOPIC
IN PARTNERSHIP WITH CRESSET
From Chat Bots to World Order: The Race for the 21st Century’s Operating System
August 7, 2025
·
1 min read
·
Lori Ellis
Brain cancer
FDA Greenlights Jazz’s Dordaviprone, First New Treatment for Ultra-Rare Brain Tumor
August 6, 2025
·
2 min read
·
Dan Samorodnitsky
Earnings
Biopharma CEOs Can’t Dodge Policy Questions as Trump Lobs Wrench into Earnings Season
August 6, 2025
·
6 min read
·
Annalee Armstrong
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
August 6, 2025
·
2 min read
·
Heather McKenzie
